Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

What are the liver enzyme requirements for starting terbinafine
Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026

Is there a generic for invokana?

See the DrugPatentWatch profile for invokana

Yes – the drug Invokana (canagliflozin) is available in generic form.

Item Brand Generic
Active ingredient Canagliflozin Canagliflozin
Drug class Sodium‑glucose cotransporter‑2 (SGLT2) inhibitor SGLT2 inhibitor
Indication Type 2 diabetes mellitus (often in combination with diet, exercise, and/or other antidiabetic agents) Same as the brand
Approval FDA‑approved 2013 FDA‑approved 2016 (generics become available after patent expiration)

Key points about the generic

Feature Generic canagliflozin Brand (Invokana)
Cost Usually 40–70 % lower than the brand Higher (depending on insurance and discounts)
Efficacy Bioequivalent – same clinical effect Same
Safety Same safety profile, including risk of genital yeast infections, urinary tract infections, ketoacidosis, and, rarely, acute kidney injury or lower‑extremity amputations Same
Availability Available in most U.S. pharmacies and many international markets (e.g., Canada, EU, Australia). Same
Formulations 100 mg tablets, 200 mg tablets (often 50 mg, 100 mg, and 200 mg in the U.S.) Same

Typical dosing (U.S. prescribing information)

  • Initial dose: 100 mg once daily (morning, with or without food).
  • Maintenance: May increase to 200 mg once daily if additional glycemic control is needed and renal function permits.
  • Renal adjustment:
    • CrCl ≥ 45 mL/min: 100–200 mg once daily.
    • CrCl 30–44 mL/min: 100 mg once daily.
    • CrCl < 30 mL/min: not recommended.

When to consider the generic

  1. Cost‑savings: Many patients and payers prefer generics because they’re cheaper and still effective.
  2. Insurance coverage: Some plans list the generic as the preferred drug, reducing copays or coinsurance.
  3. Drug availability: If the brand name is out of stock, the generic may be more readily available.

Things to watch for

  • Adverse effects: Watch for signs of ketoacidosis (nausea, vomiting, abdominal pain, rapid breathing) and monitor blood glucose and ketones if you develop these symptoms.
  • Kidney function: Regular monitoring of serum creatinine and eGFR is advised.
  • Sexual health: Increased risk of genital yeast infections—good hygiene and early treatment help.
  • Bone health: Rare reports of fractures; discuss with your provider if you have risk factors.

Bottom line

Yes, canagliflozin is available generically under the same name as the brand (Invokana). It provides the same benefits and risks as the brand drug, usually at a lower cost. If you’re interested in switching or have insurance questions, talk with your prescriber or pharmacist; they can help you choose the best option for your needs.



Other Questions About Invokana :

What is the risk of ketoacidosis with invokana? How does invokana affect the kidneys? Invokana vs jardiance price? Invokana free trial? Invokana 300 mg cost? Invokana 300 mg price? Invokana price canada?

AI-Drug Label Prescribing Information Alignment Report

35
35%
Grade D

Poor

Not Aligned

Patient Risk: Low

Summary

Only the generic-name identification is supported by the provided label excerpt (DESCRIPTION). The remaining claims are not supported by the provided label sections and include time-/market-specific regulatory availability statements that are not part of FDA-approved labeling content provided.

Category Scores

Accurate Statements

Invokana’s generic name is canagliflozin.
Supported by label section 11 DESCRIPTION stating that INVOKANA contains canagliflozin and that canagliflozin is the active ingredient.

Unsupported Statements

As of 2024 in the United States, there is no FDA-approved generic version of Invokana widely available.
Not supported by the provided label sections; the label excerpts do not contain time-specific or market-availability/regulatory-status statements about generic availability.
Most people still use Invokana by brand name unless a generic becomes available through patent resolution or in other markets.
Not supported by the provided FDA label sections; this is a market-behavior claim not present in the supplied label content.
Generics for Invokana may exist in other countries depending on local patent status.
Not supported by the provided FDA label sections; this is a patent/market/regulatory landscape claim not present in the supplied label content.

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The only verifiable claim concerns the drug’s generic name. The other unsupported statements are regulatory/market assertions rather than clinical safety information; however, inaccurate regulatory availability claims could indirectly affect decision-making.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Not Aligned

Primary Issue
Regulatory/market-availability statements about generic versions are not supported by the provided FDA label content.

Suggested Improvement
Limit responses to label-supported information. For generic/availability questions, avoid time- and market-specific assertions unless the FDA label (or provided excerpts) explicitly states them.

Drug Brand Mention Assessment

Branding Score
54
Visibility
49
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

The generic name for Invokana is canagliflozin

Core Claims
  • The generic name for Invokana is canagliflozin
  • As of 2024 there isn’t an FDA-approved generic version widely available in the United States
  • Most people still use Invokana by brand name unless a generic becomes available
Differentiators
Pricing Perception: Not Mentioned